Xpert® MTB/RIF for smear-negative presumptive TB: impact on case notification in DR Congo
DESIGN: Quasi-experimental design with 86 evaluation and 49 control clinics in Kinshasa, Democratic Republic of Congo. Smear microscopy was supported at all 135 clinics, Xpert was placed in 15 evaluation clinics and a sputum transport system was implemented for 25 satellite clinics. The number of cases notified before and during the project (July 2012–June 2013) was obtained from the National TB Program.
RESULTS: Of 27 147 presumptive TB cases presenting in clinics with access to Xpert, 5922 (21.8%) were smear-positive. Of 18 636 individuals with 3 negative microscopy results, 6920 (37.1%) underwent Xpert testing, 991 (14.3%) of whom tested positive. The number of bacteriologically positive cases increased equally in evaluation clinics (15.1%, 95%CI −2.3 to 32.6) and control clinics (13.6%, 95%CI 2.6–29.3), for a difference in increase of 1.5% (95%CI −28.8 to 31.8). There was no difference in the change in smear-negative cases (−42.4%, 95%CI −111.5 to 26.6), nor in all types of TB notified (−6.1%, 95%CI −32.5 to 20.4) between the evaluation and control clinics.
CONCLUSION: In part due to a restrictive algorithm, Xpert as follow-on to smear microscopy did not increase the overall number of TB notifications, nor the number of bacteriologically positive cases.
Document Type: Research Article
Affiliations: 1: *School of Public Health, University of Kinshasa, Kinshasa 2: †Provincial Coordination of the National TB Programme, Kinshasa, Democratic Republic of Congo 3: †Public Health, TB and HIV Consult, Tilburg, The Netherlands 4: §Stop TB Partnership, Secretariat, Geneva, Switzerland 5: Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 6: Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, Division of Epidemiology, College of Public Health, Ohio State University, Columbus, Ohio, USA
Publication date: February 1, 2016
The International Journal of Tuberculosis and Lung Disease publishes articles on all aspects of lung health, including public health-related issues such as training programmes, cost-benefit analysis, legislation, epidemiology, intervention studies and health systems research. The IJTLD is dedicated to the continuing education of physicians and health personnel and the dissemination of information on lung health world-wide.
To share scientific research of immediate concern as rapidly as possible, The Union is fast-tracking the publication of certain articles from the IJTLD and publishing them on The Union website, prior to their publication in the Journal. Read fast-track articles.
Certain IJTLD articles are also selected for translation into French, Spanish, Chinese or Russian. These are available on the Union website.
- Editorial Board
- Information for Authors
- Subscribe to this Title
- International Journal of Tuberculosis and Lung Disease
- Public Health Action
- Ingenta Connect is not responsible for the content or availability of external websites